Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting Ras with protein engineering

Oncotarget(2023)10.18632/oncotarget.28469Source: DataRank Database

Targeting Ras with protein engineering is a research paper published in Oncotarget (2023). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

uniprot pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.32)OA: goldTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Julia M. Shifman ORCID,Atílio Tomazini ORCID

Live enrichment

PubMed:37395750 PMC:PMC10317039 OpenAlex:https://openalex.org/W4382810708

NCI NIH HHS

Grant: R01 CA258274

National Institutes of Health

Grant: 5R01CA258274-02

Engineering tissue inhibitor of metalloproteinases-2 (TIMP-2) for triple negative breast cancer therapy

FWCI

1.32

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.oncotarget.com/article/28469/pdf/

publisherhttps://www.oncotarget.com/article/28469/pdf/

publisherhttps://www.oncotarget.com/lookup/doi/10.18632/oncotarget.28469

journalhttps://doi.org/10.18632/oncotarget.28469

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37395750

Fields of Study

Protein Kinase Regulation and GTPase SignalingCell death mechanisms and regulationCancer-related Molecular PathwaysHumansGenes, rasras ProteinsNeoplasmsMutationProtein EngineeringProto-Oncogene Proteins p21(ras)

MeSH Terms

HumansMutationNeoplasmsGenes, rasProtein EngineeringProto-Oncogene Proteins p21(ras)ras Proteins

Keywords

EffectorSmall moleculeSmall GTPaseHRASDrug discoveryMutantBiologyGTPaseGTPase-activating proteinCell biologyCancer cellComputational biologyMutationGeneCancerBiochemistryG proteinSignal transductionGeneticsKRASProtein engineeringRas oncogeneProtein designRas TargetingAnti-ras TherapeuticsProto-Oncogene Proteins p21(ras)Genes, rasNeoplasmsras ProteinsHumansReview